USA: Pharmaceutical Wuxi Apptec Further Develops Facilities for Pharma R&D Services
The firm aims to expand its facilities in California and the recently expanded plant will create a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D.
California/USA – Wuxi Apptec, a leading global pharmaceutical and medical device open-access capability and technology platform company has recently announced the expansion of its facilities in San Diego, California.
The company’s newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing. The expansion will provide key elements of Wuxi's small molecule capability and technology platform under one roof, further enhancing services to North American pharmaceutical and biotech industries. Wuxi will also add extensively from the local talent base, further contributing to regional economic growth.